BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28239029)

  • 1. Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomach.
    Makuuchi R; Terashima M; Kusuhara M; Nakajima T; Serizawa M; Hatakeyama K; Ohshima K; Urakami K; Yamaguchi K
    Biomed Res; 2017; 38(1):19-27. PubMed ID: 28239029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
    Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
    Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of gastric neuroendocrine carcinomas.
    Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
    Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
    Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
    Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
    Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
    Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach.
    Ishida M; Sekine S; Taniguchi H; Fukagawa T; Katai H; Kushima R
    Histopathology; 2014 Jun; 64(7):1027-31. PubMed ID: 24329753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent occurrence of gastric adenocarcinoma and duodenal neuroendocrine cell carcinoma: a composite tumour or collision tumours ?
    Fukui H; Takada M; Chiba T; Kashiwagi R; Sakane M; Tabata F; Kuroda Y; Ueda Y; Kawamata H; Imura J; Fujimori T
    Gut; 2001 Jun; 48(6):853-6. PubMed ID: 11358908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in gastric amphicrine carcinomas and comparison with gastric mixed neuroendocrine-non-neuroendocrine neoplasms.
    Sun L; Wang C; Zhang J; Shao B; Zhao S; Guo Y; Li X; Sun Y
    Mod Pathol; 2022 Jun; 35(6):808-815. PubMed ID: 34839352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of neuroendocrine components in gastric carcinomas.
    Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
    Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and protective effects of the complexin-2 gene and gene-environment interactions in schizophrenia.
    Zakharyan R; Atshemyan S; Boyajyan A
    Recent Adv DNA Gene Seq; 2014; 8(1):30-4. PubMed ID: 25564026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods.
    Galamb O; Sipos F; Molnar B; Szoke D; Spisak S; Tulassay Z
    Cytometry B Clin Cytom; 2007 Sep; 72(5):299-309. PubMed ID: 17366642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
    Komatsu H; Kakehashi A; Nishiyama N; Izumi N; Mizuguchi S; Yamano S; Inoue H; Hanada S; Chung K; Wei M; Suehiro S; Wanibuchi H
    Cancer Biomark; 2013; 13(3):171-80. PubMed ID: 23912489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.